LAVA Therapeutics NV
LVTXDelisted Nov 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840748
LAVA Therapeutics NV was delisted on Nov 21, 2025; its insiders filed their last Form 4 on Nov 17, 2025; 21 institutions reported holding it in 13F filings for Q3 2025, worth $16.1M in total; no superinvestor held it.
Holders of 5% or more of LVTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of LAVA Therapeutics NV, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Shay Capital LLC | 13G | 9.90%2.60M shares | New | Sep 26, 20251 filing | Sep 26, 2025 | SEC |
| BML Investment Partners, L.P. | 13G | 7.40%1.96M shares | New | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on LAVA Therapeutics NV, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 20254:32 PM ET | Cooperatieve Gilde Healthcare IV U.A.and 4 others | 13D/A | 3.90%1.01M shares | −7.30 ppfrom 11.20%Below 5% | Oct 20, 2025 | SEC |
| Oct 17, 20256:01 PM ET | Cooperatieve Gilde Healthcare IV U.A.and 4 others | 13D/A | 11.20%2.95M shares | −8.70 ppfrom 19.90% | Oct 15, 2025 | SEC |
| Oct 14, 20254:37 PM ET | Cooperatieve Gilde Healthcare IV U.A.and 4 others | 13D/A | 19.90%5.25M shares | – | Oct 9, 2025 | SEC |
| Sep 26, 20254:01 PM ET | Shay Capital LLCand 1 other | 13G | 9.90%2.60M shares | New | Sep 19, 2025 | SEC |
| Sep 23, 20254:52 PM ET | Versant Venture Capital VI, L.P.and 5 others | 13D/A | 0.00%0 shares | −9.00 ppfrom 9.00%Below 5% | Sep 19, 2025 | SEC |
| Sep 18, 20257:08 PM ET | Versant Venture Capital VI, L.P.and 5 others | 13D/A | 9.00%2.37M shares | – | Sep 16, 2025 | SEC |
| Mar 3, 20252:03 PM ET | BML Investment Partners, L.P. | 13G | 7.40%1.96M shares | New | Feb 26, 2025 | SEC |
| Apr 8, 2021 | Versant Venture Capital VI, L.P. | 13DOld format | – | New | – | SEC |
| Apr 8, 2021 | Redmile Group, LLC | 13GOld format | – | New | – | SEC |
| Mar 31, 202111:19 AM ET | Sanofi | 13GOld format | – | New | – | SEC |
| Mar 31, 2021 | Novo Holdings A/S | 13DOld format | – | New | – | SEC |
| Mar 31, 2021 | Cooperatieve Gilde Healthcare IV U.A. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell LAVA Therapeutics NV shares.
No Form 144 notices for LAVA Therapeutics NV are on file.